Survival in patients with Parkinson's disease: a ten-year follow

Background A thorough understanding of the factors that influence patient survival in Parkinson’s disease (PD) will aid in prognosis prediction and provide a new direction for disease modification treatment. Currently, there are no standardized mortality ratio (SMR) data for PD patients in the northern Chinese mainland. The main focus of this study was to determine which factors in the prospectively collected baseline characteristics can affect the survival of PD patients. In addition, for the first time, we investigated the SMR of PD patients in northern China. Methods Between 2009 and 2012, 218 PD patients were continuously recruited from the movement disorder clinic of the First Affiliated Hospital of Dalian Medical University and followed up until death or May 31, 2021. The prespecified prognostic variables were demographics, clinical features, lifestyle factors, and drug dose prospectively collected at baseline. To determine the independent predictors of survival during follow-up, the Cox proportional hazards model was used. Kaplan–Meier analysis was applied to estimate the overall survival curve and to compare survival between layers based on statistically significant predictors. The SMR of this northern Chinese mainland PD cohort was calculated. Results After a mean follow-up of 9.58 ± 2.27 years, 50 patients (22.90%) died. Factors that could individually predict shortened survival during follow-up included older age at onset (hazard ratio [HR] 1.10, 95% confidence interval [CI] 1.06–1.15), Hoehn and Yahr (H&Y) stage ≥ 3 (HR 9.36, 95% CI 2.82–31.03) and severe cognitive impairment (HR 6.18, 95% CI 2.75–13.88). Univariate Cox regression revealed that a certain amount of physical activity was associated with better survival (HR 0.41, 95% CI 0.22–0.74), while fatigue was associated with an increased risk of death (HR 2.54, 95% CI 1.37–4.70). The overall SMR was 1.32 (95% CI 0.98–1.74). Conclusions Older age at onset, higher baseline H&Y stage, and severe cognitive impairment have a negative impact on survival. The 10-year survival of PD patients is not significantly different from that of the general population in China.

Prediagnostic presentations of Parkinson's disease in primary care: a case-control study - ScienceDirect

10+ Facts About Parkinson's Disease: Statistics and Realities

Home Page: Parkinsonism & Related Disorders

Survival in patients with Parkinson's disease: a ten-year follow-up study in northern China, BMC Neurology

The Numbers Behind Parkinson's Disease

Five-Year Follow-up of Bilateral Stimulation of the Subthalamic Nucleus in Advanced Parkinson's Disease

Ten year survival and outcomes in a prospective cohort of new onset Chinese Parkinson's disease patients

Impact of Off-Time on Quality of Life in Parkinson's Patients and Their Caregivers: Insights from Social Media

QuickStats: Age-Adjusted Death Rates for Parkinson Disease Among Adults Aged ≥65 Years — National Vital Statistics System, United States, 1999–2017

Long-term outcomes following deep brain stimulation for Parkinson's disease in: Journal of Neurosurgery Volume 132 Issue 1 (2019) Journals

Pesticides Not Only Linked to Parkinson's Disease Development, But Accelerating Disease Symptoms - Beyond Pesticides Daily News Blog

Age at symptom onset and long-term survival in patients with neurofibromatosis Type 2 in: Journal of Neurosurgery Volume 99 Issue 3 (2003) Journals